elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51530606-79C676C9-D9FE-4D97-87E3-684F302CB1ED
Q51530606-79C676C9-D9FE-4D97-87E3-684F302CB1ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51530606-79C676C9-D9FE-4D97-87E3-684F302CB1ED
Challenges in the design of multitarget drugs against multifactorial pathologies: a new life for medicinal chemistry?
P2860
Q51530606-79C676C9-D9FE-4D97-87E3-684F302CB1ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51530606-79C676C9-D9FE-4D97-87E3-684F302CB1ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37d33e16b8df0074e8df7568b153a3b13a019739
P2860
Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.